KoBioLabs

KoBioLabs Debt / Assets

The Debt-to-Assets Ratio of KoBioLabs (348150.KQ) as of Nov 16, 2026 is 0.07. In the previous year, Debt-to-Assets Ratio was 0.12 — a change of -42.84% (lower).

Debt / Assets

0.07

YoY

-42.84%

Last updated:

Debt-to-Assets Ratio of KoBioLabs is 2025 0.07 . Debt-to-Assets Ratio of KoBioLabs was 2024 0.12 . It decreases by -42.84% lower compared to the previous year.

The KoBioLabs Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2018
0.00 KRW
Jan 1, 2019
0.00 KRW
Jan 1, 2020
0.00 KRW
Jan 1, 2021
0.07 KRW
Jan 1, 2022
0.10 KRW
Jan 1, 2023
0.08 KRW
Jan 1, 2024
0.12 KRW
Jan 1, 2025
0.07 KRW
The KoBioLabs Debt / Assets history
YEARDebt / AssetsYoY
0.07-42.84%
0.12+50.76%
0.08-15.21%
0.10+32.54%
0.07+7,355.66%
0.00-52.80%
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs Stock analysis

What does KoBioLabs do? KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets. KoBioLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KoBioLabs stock

Debt-to-Assets Ratio of KoBioLabs is 0.07 in 2025.

Debt-to-Assets Ratio of KoBioLabs changed from 0.12 to 0.07, representing a -42.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio KoBioLabs since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's KoBioLabs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — KoBioLabs

All Key Metrics — KoBioLabs